✦ LIBER ✦

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

✍ Scribed by Kentepozidis, N.; Soultati, A.; Giassas, S.; Vardakis, N.; Kalykaki, A.; Kotsakis, A.; Papadimitraki, E.; Pantazopoulos, N.; Bozionellou, V.; Georgoulias, V.

Book ID: 113028116
Publisher: Springer
Year: 2012
Tongue: English
Weight: 254 KB
Volume: 70
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1896-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel plus bevacizumab in patients

Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group

✍ Mountzios, Giannis; Emmanouilidis, Christos; Vardakis, Nikolaos; Kontopodis, Emm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Paclitaxel and carboplatin as first-line

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

✍ George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Sk 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Paclitaxel and Carboplatin as Neoadjuvan

Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group

✍ Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimost 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 847 KB

A phase II study of sorafenib in combina

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

✍ Emma K. Beardsley, Sebastien J. Hotte, Scott North, Susan L. Ellard, Eric Winqui 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

The combination of gemcitabine and carbo

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A Phase II study of the Hellenic Cooperative Oncology Group

✍ Aristotle Bamias; Lia A. Moulopoulos; Aggelos Koutras; Gerassimos Aravantinos; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract ## BACKGROUND The toxicity of platinum‐based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplati

A multicenter phase II study of carbopla

A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial

✍ Masao Ichiki; Masayuki Kawasaki; Koichi Takayama; Kiyoshi Ninomiya; Mutsuo Kuba; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 211 KB